Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Letter to the Editor - Therapy Letter
2017:83:3;392-396
doi: 10.4103/0378-6323.203080
PMID: 28366906

Response of superimposed linear psoriasis to ustekinumab: A case report

Hao-Jui Weng, Tsen-Fang Tsai
 Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan

Correspondence Address:
Tsen-Fang Tsai
Department of Dermatology, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 10048
Taiwan
How to cite this article:
Weng HJ, Tsai TF. Response of superimposed linear psoriasis to ustekinumab: A case report. Indian J Dermatol Venereol Leprol 2017;83:392-396
Copyright: (C)2017 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Linear psoriasis is a rare form of psoriasis which has been reported to concur with plaque psoriasis but may be unmasked only after the effective treatment of plaque psoriasis on other body parts.[1],[2] Most of the literature till now demonstrated that treatments effective for plaque psoriasis including adalimumab, infliximab, etanercept, methotrexate, dithranol and corticosteroids, only yielded poor to limited responses in linear psoriasis.[1],[2],[3],[4] There is only one report in which radiation therapy combined with calcipotriol and corticosteroids was somewhat effective.[5]

Here we present a case in which linear psoriasis showed inadequate response to ustekinumab, an anti-interleukin-23 monoclonal antibody. A 26-year-old otherwise healthy man was diagnosed with plaque psoriasis, two years before his visit at our clinic. His previous regimen included oral methotrexate, oral acitretin, topical calcipotriol, topical calcitriol and topical clobetasol propionate. Nevertheless, the skin lesions continued to increase. At the age of 27, he noticed linear lesions developing on his right arm. On physical examination, he had multiple individual erythematous scaly plaques coalescing to form a linear pattern on his right upper arm, shoulder and back [Figure 1a] and [Figure 1b] along with typical plaque psoriasis [Figure 1c]. Due to intolerance to other treatments, ustekinumab 45 mg was administered subcutaneously at weeks 0 and 4, followed by every 4 weeks. Over the treatment course of 18 doses, most lesions of plaque psoriasis showed a significant resolution, with psoriasis area and severity index (PASI) dropping from 14.3 to 3.2. However, linear psoriasis on the arm and back remained refractory to ustekinumab and was especially pruritic [Figure 2a],[Figure 2b],[Figure 2c]. Biopsies on the lesions from linear and plaque psoriasis were both compatible with the diagnoses of psoriasis. Acanthosis, elongation of rete ridges, hyperkeratosis, Munro's microabscesses and upper dermal lymphocytic and neutrophilic infiltration were observed in both lesions [Figure 3a] and [Figure 3b].

Figure 1a: Before the initiation of ustekinumab: Superimposed linear psoriasis on the back
Figure 1b: Before the initiation of ustekinumab: Superimposed linear psoriasis on the right arm
Figure 1c: Before the initiation of ustekinumab: Plaque psoriasis on the leg
Figure 2a: Refractory lesions of linear psoriasis after ustekinumab: Persistent lesions of linear psoriasis on the back
Figure 2b: Refractory lesions of linear psoriasis after ustekinumab: Persistent lesions of linear psoriasis on the right arm
Figure 2c: Lesions of plaque psoriasis over the legs showing improvement after ustekinumab
Figure 3a: Biopsy of linear psoriasis on the upper back showing hyperkeratosis, acanthosis and elongation of rete ridges (H and E, ×100)
Figure 3b: Biopsy of plaque psoriasis on the abdomen showing parakeratosis, acanthosis, elongation of rete ridges, Munro's micrabscesses and upper dermal infiltrate with lymphocytes and neutrophils (H and E, ×100)

Our report is the first to demonstrate the effects of ustekinumab in the treatment of linear psoriasis. Ustekinumab is an anti-interleukin-23 agent with superior efficacy compared to etanercept in a controlled trial.[6] Although ustekinumab is approved for the treatment of plaque psoriasis and psoriatic arthritis, currently there has been no report of its use in the treatment of linear psoriasis. Previous reports of anti-tumor necrosis factor-α agents for the treatment of linear psoriasis all failed to show adequate response. These agents include infliximab, etanercept and adalimumab.[1],[7] The relatively inadequate treatment response of ustekinumab in linear psoriasis compared to plaque psoriasis underlines the importance of phenotyping for psoriasis to predict biologic responsiveness.[8] In addition, targeting other pathways may be of therapeutic potential for linear psoriasis.

The differential treatment responses are consistent with the hypothesis that linear psoriasis may be a special variant of psoriasis with a nevoid nature, which is distinct from plaque psoriasis. The exact nature of linear psoriasis is not known, but a postzygotic mutation has been proposed. Moreover, the age of onset of linear psoriasis is often delayed as in our case. However, in our patient, the onset of his linear psoriasis seemed to coevolve with his plaque psoriasis. The linear form became more prominent after the resolution of his plaque psoriasis. More studies are warranted to better understand the etiology as well as the treatment of linear psoriasis.

This work was supported by a grant from the National Taiwan University Hospital. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References
1.
Colombo L, Marconi M, Mapelli ET, Crespi E, Gualandri L, Menni S, et al. Superimposed linear psoriasis: Low effectiveness of biologic therapy. G Ital Dermatol Venereol 2011;146:311-3.
[Google Scholar]
2.
Kira M, Katayama I. Superimposed linear psoriasis. J Dermatol 2010;37:1063-5.
[Google Scholar]
3.
Kao PH, Hui RY, Yang CH, Huang YH. Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan. Dermatol Sin 2015;33:119-23.
[Google Scholar]
4.
Rott S, Küster RM, Mrowietz U. Successful treatment of severe psoriatic arthritis with infliximab in an 11-year-old child suffering from linear psoriasis along lines of Blaschko. Br J Dermatol 2007;157:191-2.
[Google Scholar]
5.
Larsen F, Menter A, Cockerell CJ, Wilcox BN. Verrucous linear (segmental) psoriasis of the right leg responding to radiation therapy. J Drugs Dermatol 2008;7:969-71.
[Google Scholar]
6.
Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus-Gort R, Yeilding N, et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med 2010;362:118-28.
[Google Scholar]
7.
Arnold AW, Happle R, Itin PH. Superimposed linear psoriasis unmasked by therapy with adalimumab. Eur J Dermatol 2010;20:573-4.
[Google Scholar]
8.
Karczewski J, Poniedzialek B, Rzymski P, Adamski Z. Factors affecting response to biologic treatment in psoriasis. Dermatol Ther 2014;27:323-30.
[Google Scholar]

Fulltext Views
150

PDF downloads
85
Show Sections